Table 3 Echocardiographic parameters
From: Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease
CFVR < 2 (n = 7) | CFVR ≥ 2 (n = 15) | p value | |
|---|---|---|---|
IVSD (mm) | 12 ± 1 | 11 ± 2 | 0.610 |
LVIDD (mm) | 46 ± 9 | 47 ± 6 | 0.679 |
PWD (mm) | 10 ± 2 | 11 ± 2 | 0.789 |
LVIDS (mm) | 31 (29–36) | 30 (28–35) | 0.535 |
FS (%) | 33 ± 9 | 35 ± 5 | 0.639 |
LVEDVi (ml/m2) | 55 (49–69) | 44 (39–51) | 0.115 |
LVESVi (ml/m2) | 21 (18–28) | 18 (16–21) | 0.275 |
EF (%) | 59 ± 7 | 59 ± 4 | 0.923 |
Stroke volume (ml) | 87 ± 25 | 72 ± 20 | 0.182 |
Cardiac output (L/min) | 6.1 ± 0.8 | 4.7 ± 1.4 | 0.02 |
GLS (%) | -16 ± 3 | -19 ± 2 | 0.107 |
TAPSE (mm) | 21 ± 4 | 21 ± 5 | 0.875 |
LV mass index (g/m2) | 99 ± 31 | 98 ± 28 | 0.936 |
LV geometry n (%)—normal geometry Concentric remodelling Eccentric hypertrophy Concentric hypertrophy | 2 (29) 3 (43) 1 (14) 1 (14) | 4 (27) 1 (7) 3 (20) 7 (46) | 0.237 |
LA volume index (ml/m2) | 31.3 (26-44.1) | 28.8 (20-38.3) | 0.630 |
E/A ratio | 1.1 (0.9–1.2) | 0.8 (0.7–1.1) | 0.340 |
E/e′ | 9 (8–11) | 8 (7–10) | 0.123 |